Template:Did you know nominations/Tomáš Cihlář
< Template:Did you know nominations
Jump to navigation
Jump to search
Revision as of 23:39, 21 May 2020 by imported>John P. Sadowski (NIOSH) (review)
DYK toolbox |
---|
Tomáš Cihlář
- ... that as a student, Czech American virologist Tomáš Cihlář, known today for developing hopeful anti-Covid-19 drug remdesivir, assisted Antonín Holý in developing tenofovir disoproxil, the primary drug used in the fight against HIV?[1][2]
- ALT1:... that Czech American virologist Tomáš Cihlář is credited with developing both tenofovir disoproxil to fight HIV and remdesivir to fight Covid-19?[1][2]
- Reviewed: Template:Did you know nominations
- Created/expanded by Swmmng (talk). Self-nominated at 13:12, 23 April 2020 (UTC).
Template:Ping New and long enough, Earwig detects no copyvios. I'd like to see more specifics and better sourcing about Cihlář's involvement in developing remdesivir; these are generally large team efforts and simply saying he developed it himself isn't sufficient detail. Was he a laboratory scientist, a research group head, or was it in his executive position at Gilead? John P. Sadowski (NIOSH) (talk) 23:39, 21 May 2020 (UTC)
- ↑ 1.0 1.1 Anon., "Remdesivir Cleared For Use On Covid-19 Patients in Four Czech Hospitals", Prague Morning, April 29, 2020.
- ↑ 2.0 2.1 Saiver, F., "Je Remdesivir lékem na covid-19? O objevu týmu Tomáše Cihláře má být jasno už do konce dubna", Forbes, April 8, 2020.